These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients. Preiksaitis JK. Clin Infect Dis; 2004 Oct 01; 39(7):1016-23. PubMed ID: 15472855 [Abstract] [Full Text] [Related]
4. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Preiksaitis JK, Keay S. Clin Infect Dis; 2001 Jul 01; 33 Suppl 1():S38-46. PubMed ID: 11389521 [Abstract] [Full Text] [Related]
5. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B. Ann Hematol; 2006 Jul 01; 85(7):478-84. PubMed ID: 16586109 [Abstract] [Full Text] [Related]
6. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Johnson LR, Nalesnik MA, Swerdlow SH. Am J Surg Pathol; 2006 Dec 01; 30(12):1604-12. PubMed ID: 17122518 [Abstract] [Full Text] [Related]
7. Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas. Swinnen LJ. Semin Oncol; 2000 Aug 01; 27(4):402-8. PubMed ID: 10950366 [Abstract] [Full Text] [Related]
8. Posttransplant lymphoproliferative disorder. Everly MJ, Bloom RD, Tsai DE, Trofe J. Ann Pharmacother; 2007 Nov 01; 41(11):1850-8. PubMed ID: 17940127 [Abstract] [Full Text] [Related]
9. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH, Russ GR, Coates PT. Nephrology (Carlton); 2006 Aug 01; 11(4):355-66. PubMed ID: 16889577 [Abstract] [Full Text] [Related]
10. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ. Am J Surg Pathol; 2006 Mar 01; 30(3):328-36. PubMed ID: 16538052 [Abstract] [Full Text] [Related]
11. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Transpl Int; 2007 Mar 01; 20(3):207-18. PubMed ID: 17291214 [Abstract] [Full Text] [Related]
12. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis. Capello D, Berra E, Cerri M, Gaidano G. Minerva Med; 2004 Feb 01; 95(1):53-64. PubMed ID: 15041926 [Abstract] [Full Text] [Related]
13. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438 [Abstract] [Full Text] [Related]
14. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC. J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157 [Abstract] [Full Text] [Related]